BURLINGTON, Mass., Nov. 14, 2011 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced today that it has been selected by the specialty biopharmaceutical company Santarus, Inc. to provide sales operations support, as well as recruiting and sales force automation services, for the organization's prescription products for Type 2 diabetes.
inVentiv Health will deliver the outsourced sales services through the company's Selling Solutions business. It offers flexible staffing solutions to a wide range of clients in the pharmaceutical, biotechnology, medical device, diagnostic, long-term care, and pharmacy and managed care industries.
"inVentiv is extremely pleased to be collaborating with Santarus again," said Paul Mignon, President, inVentiv Health Selling Solutions. "We look forward to putting our experienced sales teams and best-in-class recruiting and sales force automation services to work for our long-term client and its vitally important medicines for patients."
Gerry Proehl, President and CEO, Santarus, Inc., said: "We have contracted with inVentiv Health to expand our field sales organization based on our positive past experience with this organization. By working with inVentiv and adding sales representatives, we intend to increase call frequency and share of voice with our called-on physicians, as well as improve sales representative efficiency by reducing territory size and increasing the number of sales calls made each day."
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine mesylate) tablets, w
|SOURCE inVentiv Health, Inc.|
Copyright©2010 PR Newswire.
All rights reserved